We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$2.54B
Cap. Flow
+$1.55B
Cap. Flow %
7.41%
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$798M
2
XOM icon
ExxonMobil
XOM
+$189M
3
CTSH icon
Cognizant
CTSH
+$86.4M
4
MRK icon
Merck
MRK
+$80.6M
5
IART icon
Integra LifeSciences
IART
+$47.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$57.5M
2
PEP icon
PepsiCo
PEP
+$55.1M
3
DG icon
Dollar General
DG
+$49.7M
4
WOOF
VCA Inc.
WOOF
+$48.1M
5
SPG icon
Simon Property Group
SPG
+$45.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.52%
2 Technology 14.11%
3 Financials 12.07%
4 Industrials 10.58%
5 Consumer Discretionary 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRS icon
1551
Carpenter Technology
CRS
$28.4B
$29K ﹤0.01%
800
CSGP icon
1552
CoStar Group
CSGP
$12B
$29K ﹤0.01%
1,400
GIL icon
1553
Gildan
GIL
$9.31B
$29K ﹤0.01%
1,124
IONS icon
1554
Ionis Pharmaceuticals
IONS
$9.34B
$29K ﹤0.01%
724
+14
+2% +$629
NWN icon
1555
Northwest Natural Holdings
NWN
$2.17B
$29K ﹤0.01%
500
OII icon
1556
Oceaneering
OII
$5.13B
$29K ﹤0.01%
1,107
+107
+11% +$2.92K
XT icon
1557
iShares Future Exponential Technologies ETF
XT
$3.77B
$29K ﹤0.01%
1,000
AGRX
1558
DELISTED
Agile Therapeutics
AGRX
$29K ﹤0.01%
5
ATHX
1559
DELISTED
Athersys, Inc. Common Stock
ATHX
$29K ﹤0.01%
700
WFC.PRN
1560
DELISTED
WELLS FARGO & COMPANY Depositary Shares, representing a 1/1,000th interest in a share of Non-Cumulat
WFC.PRN
$29K ﹤0.01%
1,200
CNOB icon
1561
Center Bancorp
CNOB
$1.64B
$28K ﹤0.01%
+1,184
New +$29.2K
FSLR icon
1562
First Solar
FSLR
$21.6B
$28K ﹤0.01%
1,049
+921
+720% +$30.2K
FWONK icon
1563
Liberty Media Series C
FWONK
$24.7B
$28K ﹤0.01%
865
-27
-3% -$832
GLAD icon
1564
Gladstone Capital
GLAD
$432M
$28K ﹤0.01%
1,501
GNRC icon
1565
Generac Holdings
GNRC
$11.4B
$28K ﹤0.01%
770
+70
+10% +$2.77K
INDA icon
1566
iShares MSCI India ETF
INDA
$6.74B
$28K ﹤0.01%
892
+20
+2% +$586
KRC icon
1567
Kilroy Realty
KRC
$4.56B
$28K ﹤0.01%
391
RRD
1568
DELISTED
RR Donnelley & Sons Co.
RRD
$28K ﹤0.01%
2,378
+213
+10% +$3.4K
OLBK
1569
DELISTED
Old Line Bancshares, Inc.
OLBK
$28K ﹤0.01%
1,000
BRCD
1570
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$28K ﹤0.01%
2,253
-7,021
-76% -$87.2K
TELN
1571
DELISTED
TELENOR ASA
TELN
$28K ﹤0.01%
1,728
+324
+23% +$5.25K
SBB
1572
DELISTED
SUSSEX BANCORP
SBB
$28K ﹤0.01%
1,150
ALV icon
1573
Autoliv
ALV
$8.61B
$27K ﹤0.01%
376
-122
-24% -$9.44K
JD icon
1574
JD.com
JD
$41.7B
$27K ﹤0.01%
890
-23,047
-96% -$678K
LGF.B
1575
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$27K ﹤0.01%
1,141
-27
-2% -$685

Similar funds

Glenmede Trust's Q1 2017 Portfolio in Review

As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.

  • Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
  • Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
  • Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
  • Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
  • Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
  • Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
  • Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.